PL3284506T3 - Rozpuszczalna mikroigła zawierająca składnik do kontroli uwalniania neuroprzekaźników - Google Patents

Rozpuszczalna mikroigła zawierająca składnik do kontroli uwalniania neuroprzekaźników

Info

Publication number
PL3284506T3
PL3284506T3 PL16780268T PL16780268T PL3284506T3 PL 3284506 T3 PL3284506 T3 PL 3284506T3 PL 16780268 T PL16780268 T PL 16780268T PL 16780268 T PL16780268 T PL 16780268T PL 3284506 T3 PL3284506 T3 PL 3284506T3
Authority
PL
Poland
Prior art keywords
neurotransmitters
controlling release
containing ingredient
soluble microneedle
microneedle containing
Prior art date
Application number
PL16780268T
Other languages
English (en)
Inventor
Nae-Gyu Kang
Hyun-Jong Lee
Yun-Hee Chang
Tae-Yoon Kim
Ki-Young Kim
Woo-Sun Shim
Original Assignee
Lg Household & Health Care Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020150144855A external-priority patent/KR102203633B1/ko
Priority claimed from KR1020150159978A external-priority patent/KR102099326B1/ko
Application filed by Lg Household & Health Care Ltd. filed Critical Lg Household & Health Care Ltd.
Priority claimed from PCT/KR2016/003845 external-priority patent/WO2016167545A1/ko
Publication of PL3284506T3 publication Critical patent/PL3284506T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0023—Drug applicators using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0046—Solid microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0061—Methods for using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2207/00—Methods of manufacture, assembly or production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Medical Informatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL16780268T 2015-04-13 2016-04-12 Rozpuszczalna mikroigła zawierająca składnik do kontroli uwalniania neuroprzekaźników PL3284506T3 (pl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
KR20150052043 2015-04-13
KR20150052575 2015-04-14
KR1020150144855A KR102203633B1 (ko) 2015-04-14 2015-10-16 칼슘채널 차단제 전달용 용해성 미세바늘
KR1020150159978A KR102099326B1 (ko) 2015-04-13 2015-11-13 폴리페놀 전달용 용해성 마이크로니들
EP16780268.5A EP3284506B1 (en) 2015-04-13 2016-04-12 Soluble microneedle containing ingredient for controlling release of neurotransmitters
PCT/KR2016/003845 WO2016167545A1 (ko) 2015-04-13 2016-04-12 신경전달물질의 배출을 조절하는 성분이 포함된 용해성 마이크로니들

Publications (1)

Publication Number Publication Date
PL3284506T3 true PL3284506T3 (pl) 2021-10-25

Family

ID=60423061

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16780268T PL3284506T3 (pl) 2015-04-13 2016-04-12 Rozpuszczalna mikroigła zawierająca składnik do kontroli uwalniania neuroprzekaźników

Country Status (6)

Country Link
US (2) US10391289B2 (pl)
EP (1) EP3284506B1 (pl)
JP (1) JP6784442B2 (pl)
CN (1) CN107427474A (pl)
HK (1) HK1247575A1 (pl)
PL (1) PL3284506T3 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10391289B2 (en) * 2015-04-13 2019-08-27 Lg Household & Health Care Ltd. Soluble microneedle containing ingredient for controlling release of neurotransmitters
WO2019102992A1 (ja) 2017-11-21 2019-05-31 積水化学工業株式会社 皮膚外用剤
KR102169116B1 (ko) * 2019-02-22 2020-10-22 주식회사 엘지생활건강 신경전달물질 분비 억제 조성물
CN113350263B (zh) * 2021-06-04 2022-05-17 贵州中医药大学 一种雷公藤甲素自溶性微针
CN114259479B (zh) * 2021-12-16 2024-04-02 澳门大学 一种微针、微针贴片及其制备方法
CN114848613A (zh) * 2022-05-09 2022-08-05 山东中医药大学 一种东莨菪碱可溶性微针贴片及其制备方法和应用

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020050135A (ko) * 2000-12-20 2002-06-26 조명재 피부 주름 예방 및 완화를 목적으로 하는 피부 외용 조성물
US20040009180A1 (en) 2002-07-11 2004-01-15 Allergan, Inc. Transdermal botulinum toxin compositions
US7071167B2 (en) 2002-11-13 2006-07-04 L'oreal Use of a combination of components with an inhibitory synergistic effect on calcium channels to prevent or treat wrinkles and fine lines
FR2846885B1 (fr) * 2002-11-13 2004-12-24 Oreal Utilisation d'une association de composants a effet synergique inhibiteur de canaux calciques pour prevenir ou traiter les ridules
KR20070091630A (ko) * 2004-12-29 2007-09-11 라보 코스프로파르 아게 표정 주름을 이완시키는데 적합한 피부 적용을 위한 미용조성물
EP1844763B2 (en) * 2005-01-31 2022-09-07 BioSerenTach Co., Ltd. Percutaneously absorbable preparation, percutaneously absorbable preparation holding sheet, and percutaneously absorbable preparation holding equipment
KR100883757B1 (ko) * 2007-03-12 2009-02-12 성균관대학교산학협력단 신경전달물질 배출을 조절하기 위한 폴리페놀 화합물
TW200841866A (en) 2007-04-25 2008-11-01 Micro Base Technology Corp Cosmetic or medical patch structure
WO2008134712A2 (en) * 2007-04-30 2008-11-06 Living Proof, Inc. Use of matrix metalloproteinase inhibitors in skin care
MX2010002247A (es) * 2007-09-04 2010-05-17 Oreal Uso de una combinacion de hesperidina y de un microorganismo para influir en la funcion de barrera de la piel.
ES2494853T3 (es) 2007-11-02 2014-09-16 Acrux Dds Pty Ltd Sistema de administración transdérmica
KR100901074B1 (ko) 2008-09-03 2009-06-03 성균관대학교산학협력단 신경전달물질 배출을 조절하기 위한 폴리페놀 화합물
KR101451989B1 (ko) * 2008-10-13 2014-10-21 주식회사 엘지생활건강 피부재생용 화장료 조성물
DK3332805T3 (da) 2008-12-31 2022-05-16 Revance Therapeutics Inc Injicerbare botulinumtoksinformuleringer
DE102009055916A1 (de) * 2009-11-27 2011-06-01 Beiersdorf Ag Verwendung von Dihydromyricetin gegen Altershaut
SG183421A1 (en) 2010-02-24 2012-09-27 Hisamitsu Pharmaceutical Co Micro-needle device and preparation method
US20110305735A1 (en) 2010-06-09 2011-12-15 Lipotec, S.A. Skin antiaging treatment
WO2012092628A2 (en) * 2010-12-31 2012-07-05 Incube Labs, Llc Patches and methods for the transdermal delivery of agents to treat hair loss
FR2973237A1 (fr) * 2011-03-31 2012-10-05 Oreal Procede de traitement cosmetique fractionne utilisant un laser ou des micro-aiguilles
KR101633137B1 (ko) 2011-06-14 2016-06-23 가천대학교 산학협력단 약물 전달을 위한 리포좀-마이크로 구조체 및 이의 제조방법
WO2013151044A1 (ja) 2012-04-05 2013-10-10 久光製薬株式会社 穿刺装置及びその製造方法
EP2842595B1 (en) 2012-04-25 2019-03-20 MEDRx Co., Ltd. Microneedle and microneedle array
CN104379020A (zh) * 2012-06-29 2015-02-25 Elc管理有限责任公司 包含一种或多种化妆品成分的微针
US9789047B2 (en) 2012-07-13 2017-10-17 Phyto Tech Corp. Treating hair loss and delaying aging of skin
US10420921B2 (en) 2012-09-13 2019-09-24 Avraham Amir Delivery devices and methods for skin augmentation
MX2015008157A (es) * 2012-12-21 2016-02-22 Corium Int Inc Microarreglo para la entrega de agente terapeutico y metodos de uso.
US11000472B2 (en) 2015-04-06 2021-05-11 Lg Household & Health Care Ltd. Soluble microneedle for delivering poorly-soluble drug
KR102099326B1 (ko) 2015-04-13 2020-04-09 주식회사 엘지생활건강 폴리페놀 전달용 용해성 마이크로니들
US10391289B2 (en) * 2015-04-13 2019-08-27 Lg Household & Health Care Ltd. Soluble microneedle containing ingredient for controlling release of neurotransmitters

Also Published As

Publication number Publication date
JP2018511615A (ja) 2018-04-26
US10391289B2 (en) 2019-08-27
EP3284506B1 (en) 2021-04-28
US20180085565A1 (en) 2018-03-29
US11577063B2 (en) 2023-02-14
EP3284506A1 (en) 2018-02-21
EP3284506A4 (en) 2018-11-21
HK1247575A1 (zh) 2018-09-28
US20190336742A1 (en) 2019-11-07
CN107427474A (zh) 2017-12-01
JP6784442B2 (ja) 2020-11-11

Similar Documents

Publication Publication Date Title
HK1249728B (zh) 控制釋放的藥物劑型
IL280485A (en) Sustained-release pridopidine preparations
HK1247575A1 (zh) 含有調節神經遞質釋放的成分的可溶性微針
SG11201706729SA (en) Derivatives of sobetirome
IL263050B (en) History of Subtirum
IL259273A (en) Porous structures for sustained release drug delivery devices
IL265856A (en) Preparations for the administration of aflornithine
IL266022A (en) Capsule with controlled release
EP3383967A4 (en) SOLID BOILER PREAMBLE WITH CONTROLLED RELEASE
HK1253677A1 (zh) 緩釋薄膜包衣膠囊
GB201522764D0 (en) Formulations of phosphate derivatives
SG11201706081SA (en) Alum-containing coating formulations for microneedle vaccine patches
HK1215385A1 (zh) 改進釋放的被覆蓋的膠囊
SI3145499T1 (sl) Obložene kapsule s prirejenim sproščanjem
HUE050890T2 (hu) Nilotinib sók szilárd halmazállapotú formái
GB201504110D0 (en) Prosthesis casting device
ZA201701063B (en) Plurimodal release formulation of doxylamine and pyridoxine and/or metabolites or salts thereof
HUP1500506A2 (en) Salts of palbociclib
HK1257509A1 (zh) 包含萘醌腙或其一種鹽的脈衝釋放藥物組合物
GB201417646D0 (en) Formulations of phosphate derivatives
GB201512635D0 (en) Uses of therapeutic compounds